Replies to post #218119 on Biotech Values

[DewDiligence]

FIXX closes +17% on first day of trading, despite the IPO’s upsizing and pricing at the high end of the anticipated range. It’s informative—and perhaps unsettling—that there was so much demand for such a high-risk name.

[DewDiligence]

FIXX -24%/AH on GT data in phenylketonuria:

https://finance.yahoo.com/news/homology-medicines-announces-encouraging-initial-210110194.html

FIXX is now trading at roughly its IPO price from Mar 2018 (#msg-139606493).